Search
for
Sort by
Research 31–60 of 1000+
- JAK inhibition decreases the autoimmune burden in Down syndrome
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- BRAF Inhibitor Dabrafenib in Patients with Metastatic <i>BRAF</i>-Mutant Thyroid Cancer
- Wound healing with topical BRAF inhibitor therapy in a diabetic model suggests tissue regenerative effects
- Exploiting the origins of Ras mediated squamous cell carcinoma to develop novel therapeutic interventions
- 258 11β-hydroxysteroid dehydrogenase type 1 inhibition attenuates the adverse effects of glucocorticoids on dermal papilla cells
- Changes in Expression and Function of Extrasynaptic GABA<sub>A</sub>Receptors in the Rat Hippocampus during Pregnancy and after Delivery
- Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- Spontaneous tumour regression in keratoacanthomas is driven by Wnt/retinoic acid signalling cross-talk
- Molecular targeted therapies for cancer: Sorafenib mono�therapy and its combination with other therapies (Review)
- Advances in the Management of Cutaneous Toxicities of Targeted Therapies
- RASopathic alopecia: Hair changes associated with vemurafenib therapy
- Chemotherapy-induced iatrogenic injury of skin: New drugs and new concepts
- Analysis of lncRNAs Expression Profiles in Hair Follicle of Hu Sheep Lambskin
- Establishment of an Efficient Primary Culture System for Human Hair Follicle Stem Cells Using the Rho-Associated Protein Kinase Inhibitor Y-27632
- The concealed side of caspases: beyond a killer of cells
- Cardiodermatology: the heart of the connection between the skin and cardiovascular disease
- New small molecules in dermatology: for the autoimmunity, inflammation and beyond
- Enzyme Inhibitors from Gorgonians and Soft Corals
- Dermatologic adverse events associated with chemotherapy and targeted anticancer therapy
- 12-O-Tetradecanoylphorbol-13-acetate Induces Apoptosis in Renal Epithelial Cells through a Growth Signal Conflict Which Is Prevented by Activated ras1
- Dermatologic Adverse Events from Cancer Treatments
- Management of Toxicities of Targeted Therapies
- Skin
- LUPUS ERYTHEMATOSUS AND THE SKIN
- The role of janus kinases in the treatment of autoimmune skin diseases
- Decoding Hyperpigmentation from Biological Mechanisms to Actives with Clinically Proven Topical Efficacy: A Narrative Review
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- Dermatologic Side Effects of Systemic Targeted Anticancer Therapy